NEW YORK (GenomeWeb news) – IDBS said today that the Chinese contract research organization PharmaLegacy Laboratories will use its E-Workbook Suite to handle information for its pharmacology services.
Shanghai-based PharmaLegacy will use the company’s preclinical data management suite, including the BioBook biology extension software.
IDBS said the E-WorkBook suite will help the drug developer to “increase client productivity and the pace of drug development by providing effective management and analysis of complex research data.”
PharmaLegacy’s VP of Corporate Planning, Tom Tillotson, said in a statement that BioBook will enable the CRO to “develop long-term partnerships with biotechnology and pharmaceutical clients.”
Financial terms of the agreement were not released.